Literature DB >> 2493251

Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases.

H M Tsai1, R L Nagel, V B Hatcher, I I Sussman.   

Abstract

We have previously found that the von Willebrand factor released by cultured human umbilical vein endothelial cells appeared as a single high molecular weight band in glyoxyl agarose electrophoresis. In the present studies we report that this high molecular weight endothelial cell-derived von Willebrand factor, when incubated with granulocyte lysates, was cleaved into a series of multimers indistinguishable from those seen in normal plasma (or type II von Willebrand disease). This von Willebrand factor-cleaving activity was released from granulocytes by calcium ionophore A23187 but was not detected in cytosolic fractions depleted of granular contents. It was inhibited by the serine protease inhibitor phenylmethylsulfonyl fluoride. This von Willebrand factor-cleaving activity thus provides a possible mechanism for the generation of plasma von Willebrand factor multimers from the high molecular weight form of von Willebrand factor secreted by endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493251     DOI: 10.1016/0006-291x(89)92818-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Current concepts in thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

2.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

3.  Why Do We Need ADAMTS13?

Authors:  Han-Mou Tsai
Journal:  Nihon Kessen Shiketsu Gakkai shi       Date:  2005

Review 4.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

5.  Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.

Authors:  Thomas J Raife; Wenjing Cao; Bonnie S Atkinson; Bruce Bedell; Robert R Montgomery; Steven R Lentz; George F Johnson; X Long Zheng
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

6.  Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity.

Authors:  Martine J Hollestelle; Ka Wai Lai; Marcel van Deuren; Peter J Lenting; Philip G de Groot; Tom Sprong; Niels Bovenschen
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

7.  Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.

Authors:  Nikolett Wohner; András Kovács; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2011-12-15       Impact factor: 3.944

8.  Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature.

Authors:  Farhanah Yousaf; Bruce Spinowitz; Chaim Charytan; Marilyn Galler
Journal:  Case Rep Med       Date:  2017-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.